Evidence map›Paper›PMID 40806296›Full record

ArticleInternational journal of molecular sciences2025

Extracellular Vesicles of Adipose Multipotent Mesenchymal Stromal Cells Propagate Senescent Phenotype by Affecting PTEN Nuclear Import.

Elizaveta Chechekhina, Semyon Kamenkov, Vadim Chechekhin, Anna Zinoveva, Elizaveta Bakhchinyan, Anastasia Efimenko, Natalia Kalinina, Vsevolod Tkachuk, Konstantin Kulebyakin, Pyotr Tyurin-Kuzmin

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elizaveta ChechekhinaMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0002-5377-2712
Semyon KamenkovMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0009-0005-7005-3399
Vadim ChechekhinMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.
Anna ZinovevaMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.
Elizaveta BakhchinyanMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.
Anastasia EfimenkoMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0002-0696-1369
Natalia KalininaMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0003-3497-9619
Vsevolod TkachukMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.
Konstantin KulebyakinMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0001-6954-5787
Pyotr Tyurin-KuzminMedical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.

Funding

Russian Science Foundation 19-75-30007
6 · The paper itself

Abstract

Replicative or stress-induced senescence disrupts the functioning of multipotent mesenchymal stromal cells (MSCs) required for tissue renewal and regeneration. Aged MSCs demonstrate reduced proliferation, impaired differentiation, and aberrant secretory activity, defined as "senescence-associated secretory phenotype" (SASP). SASP is characterized by elevated secretion of proinflammatory cytokines and specific extracellular vesicles (SASP-EVs), which affect the cellular microenvironment and promote tissue dysfunction. However, molecular mechanisms responsible for senescent phenotype propagation remain largely obscure. Earlier, we demonstrated suppression of adipogenic differentiation and insulin sensitivity of young MSCs by SASP-EVs. In this study, we elucidated potential mechanisms underlying SASP-EVs' effects on MSCs. Bioinformatic analysis revealed that insulin signaling components are the most probable targets of SASP-EVs microRNA cargo. We demonstrated that SASP-EVs downregulated intracellular AGO1 levels, but surprisingly, PTEN levels were upregulated. Specifically, the increase in PTEN content was provided by its nuclear fraction. We have found that the intracellular PTEN distribution in young MSCs treated by SASP-EVs was similar to senescent MSCs. Furthermore, PTEN upregulation was accompanied by increased

Indexed as

Adipose TissueCellular SenescenceExtracellular VesiclesMesenchymal Stem CellsPTEN PhosphohydrolaseSenescence-Associated Secretory PhenotypeActive Transport, Cell NucleusCell DifferentiationCell NucleusCells, CulturedHumansMicroRNAsPhenotypeSignal TransductionMicroRNAsPTEN PhosphohydrolasePTEN protein, humancellular senescenceextracellular vesiclesinsulin resistancemesenchymal stem cellsmicroRNAsPTEN nuclear importSASP

Identifiers

PMID40806296
PMCPMC12345871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.